pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

827 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT776Endpoints580BioPharma Dive223onclive165Fierce Biotech54BioSpace52raps24
therapy area
allOncology81Cardiology27Psychiatry & CNS21Vaccines17Immunology17Rare Disease12Hepatology6
  • FDA raises no major red flags with Moderna's flu shot
    The FDA provided tepid support of Moderna’s flu vaccine ahead of an advisory meeting but, more importantly, didn't appear to raise any major concerns that could hinder its prospects. In briefing…
    Endpoints · 1mo ago↗ source
  • FDA greenlights Colorado's drug import proposal
    The FDA gave the go-ahead for Colorado to try importing cheaper drugs from Canada, but it remains to be seen how or when this would actually begin. In a letter Monday ...
    Endpoints · 1mo ago↗ source
  • Lilly buys non-opioid pain drugmaker 4E
    <figure><div><img src="https://imgproxy.divecdn.com/iu2ROUnJIMOIcb3KSFNQX1F_E37uDKtpsPUAwSV_KTo/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMDkyNDgxMzQwX1huc…
    BioPharma Dive · 1mo ago
← prev
page 14 of 34
next →
Hematology6
Pulmonology5
Infectious Disease4
Ophthalmology3
Dermatology2
↗ source
  • Express Scripts, PCMA sue to block Tennesee law breaking up PBMs and pharmacies
    <figure><div><img src="https://imgproxy.divecdn.com/yGRm0BVvV0FRQEiuWFXO6DIhLRxS2AfQRWWXVu3Olwc/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0yMTYzNzM0OTUwLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • FDA staff scrutinizes evidence supporting Moderna’s flu vaccine
    <figure><div><img src="https://imgproxy.divecdn.com/OJs2JMlOuL6tHcK-0IUh-ddLSEy1yS6jzGMiAhl9CGY/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMjg4NjcwMjY5LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Edgewise to advance heart drug into Phase 3 following mid-stage data update
    Edgewise Therapeutics has shared plans to advance its drug candidate for a genetic heart disease into a registrational study on the back of updated Phase 2 data. The biotech said Tuesday ...
    Endpoints · 1mo ago↗ source
  • How to launch a telehealth business in one day
    Want to prescribe GLP-1s online? OpenLoop Health says it can get your virtual care company up and running in as little as 24 hours. OpenLoop provides the behind-the-scenes medical group powering…
    Endpoints · 1mo ago↗ source
  • Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pill
    Plus, news about Merck, MultiValent Biotherapies, Alvotech, enGene, Mirum, and Adaptive Biotechnologies. 💸 Eli Lilly acquires another pain biotech: The Indianapolis pharma giant has made its 11t…
    Endpoints · 1mo ago↗ source
  • Edgewise heart drug passes key trial test
    <figure><div><img src="https://imgproxy.divecdn.com/-_-j1ksVvt--CzTabcyO04fqPKqSm8e8ryaYmMbBK0g/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMzg3Mjk4OTE3LmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Neumora depression drug fails; EnGene to cut 50% of staff
    <figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…
    BioPharma Dive · 1mo ago↗ source
  • [Podcast] (Season 2) The Progress Profile: Alzheimer’s Research in Focus
    <p>This podcast explores how leading Alzheimer’s experts are working to bridge the gap between clinical trial design and frontline care.</p>
    BioPharma Dive · 1mo ago↗ source
  • UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancer
    Glioblastoma is notoriously good at evading the immune system, making it particularly resistant to immunotherapy, but now researchers may have found a clever workaround. Scientists at the Universi…
    Endpoints · 1mo ago↗ source
  • CMS seeks to close Medicare negotiation 'loophole'
    CMS has proposed a policy change that clarifies its stance on how products are grouped together for Medicare negotiations. Under the Inflation Reduction Act, biologics become eligible for Medicar…
    Endpoints · 1mo ago↗ source
  • FDA plans to keep Makary priorities on trials, China, deputy says
    PHILADELPHIA – Following the recent departures of FDA Commissioner Marty Makary and both of his center directors for drugs and biologics, the Trump administration will continue pushing their priori…
    Endpoints · 1mo ago↗ source
  • Takeda fortifies orexin potential with more Phase 3 data
    With a formidable new competitor set to enter the orexin development race, Takeda is out with new data that it hopes will reinforce market-leading potential. The additional results from Takeda’s…
    Endpoints · 1mo ago↗ source
  • Elicio’s KRAS cancer vaccine fails in Phase 2, shares plummet
    Elicio Therapeutics’ pancreatic cancer vaccine failed to improve outcomes in a mid-stage study, but the company is seeking funds to move ahead to a larger Phase 3 trial anyway. Elicio reported ...
    Endpoints · 1mo ago↗ source
  • Gan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma data
    Plus news about Sanofi, PharmaMar, Jazz, Rhythm Pharmaceuticals, Spyre and Zymeworks 🇨🇳 Another obesity readout from China: Gan & Lee Pharmaceuticals, a China-based insulin specialist, anno…
    Endpoints · 1mo ago↗ source
  • Neumora drug fails two more Phase 3 trials, biotech to lay off 35% of staff
    The Really Big Neuroscience Company is proving to be a Really Big Flop with each passing update. Neumora Therapeutics will discontinue its lead depression drug after it failed another two Phase 3…
    Endpoints · 1mo ago↗ source
  • Medicare drug price rule may target under-the-skin Keytruda and Opdivo
    <figure><div><img src="https://imgproxy.divecdn.com/yNFj1iOXXiGXHrvNzMITrI7Zf52PfwK1rovRc0StZW8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMDQ3NTA1MDAwLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • Six leaders working on LGBTQ+ inclusion in biopharma
    It’s been a tough 18 months for the LGBTQ+ community. The American Civil Liberties Union tracked 530 anti-LGBTQ bills across dozens of states this year. Nearly 40% of US workers say ...
    Endpoints · 1mo ago↗ source
  • Lilly scores early positive data for new JAK drug
    <figure><div><img src="https://imgproxy.divecdn.com/BektaG64-yby8Y5l-Eb4j51Y6ClyucnWH1-PThZhx4E/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDE0NDc0NzEzLmpwZ…
    BioPharma Dive · 1mo ago↗ source
  • J&J multiple myeloma drug gains edge in earlier stage disease
    <figure><div><img src="https://imgproxy.divecdn.com/cm_W-FdbiM9BbB0zoOGzQIxUTIYDjzY9Hg-zhECEdaE/g:nowe:208:253/c:1738:982/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS85MzMxNjUxLWZh…
    BioPharma Dive · 1mo ago↗ source
  • Lilly puts its stamp at #EHA26 with Jaypirca combo data in CLL, first clinical data from Ajax buyout
    Eli Lilly made a push in blood cancer at this year’s European Hematology Association meeting in Stockholm over the weekend. The drugmaker presented data for Jaypirca combined with the standard of…
    Endpoints · 1mo ago↗ source
  • Celiac disease is entering a new era of therapeutic innovation
    <p>For the ~1 in 100 people living with celiac, the burden of disease extends far beyond their plate.</p>
    BioPharma Dive · 1mo ago↗ source
  • Planning a successful pivot from lab to clinic
    <p>For sterile injectables, key early decisions can have a significant impact on the products’ development.</p>
    BioPharma Dive · 1mo ago↗ source